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NGTNAG-thiazoline (NGT) and its derivatives are well-known inhibitors against most b-acetylglucosami-
nidases (b-GlcNAcases) except for insect and bacterial chitinolytic b-GlcNAcases, including the molt-
ing-indispensable OfHex1 from the insect Ostrinia furnacalis. Here, we report the co-crystal
structure of OfHex1 in complex with NGT. This structure reveals a large active pocket in OfHex1 that
may account for the poor inhibitory activity of NGT. To test this hypothesis, a bulky substituent was
designed and synthesized on the thiazoline ring of NGT. The resulting compound (NMAGT) was
determined to be a submicromolar inhibitor of OfHex1 with a Ki value of 0.13 lM, which is 600-fold
lower than Ki value of NGT. Molecular dynamics simulation analysis supported the good ﬁt of
NMAGT to the active pocket.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Glycosyl hydrolase family 20 b-acetylglucosaminidases (GH20
b-GlcNAcases) catalyze the removal of b1,2, b1,3, b1,4 or b1,6-
linked N-acetyl-D-glucosamine (GlcNAc) or N-acetyl-D-galactos-
amine from free or conjugated glycans. They are universally dis-
tributed in all life kingdoms and are essentially involved in many
physiological and pathological processes such as extracellular scaf-
fold remodeling, glycoconjugate processing, fertilization and path-
ogen invasion [1]. Therefore, inhibitors of GH20 b-GlcNAcases are
potential chemical tools for revealing their physiological roles
and/or potential drugs for medicinal treatment or crop protection
[2].
The reported inhibitors against GH20 b-GlcNAcases include
NAG-thiazoline (NGT, Fig. 1B) [3], DNJNAc and other iminocyclitols
[4–10], PUGNAc [11], nagstatin [12], TMG-chitotriomycin [13,14],
pochonicine [15,16], naphthalimides [17–20] and pyrimethamine
[21]. Among them, NGT was the only one speciﬁcally designed to
be an analog of the oxazolinium reaction intermediate based on
the substrate-assisted mechanism, an attractive starting point to
develop potent inhibitors (Fig. 1A). Derivatives of NGT are reportedto against other glycosyl hydrolases that use the same substrate-
assisted mechanism as GH20 b-GlcNAcases do [23]. By replacing
the methyl group on the thiazoline ring with an ethylamino group,
the NGT derivative thiamet-G, has been developed as a potent and
highly selective inhibitor against GH84 O-GlcNAcase [22,24]. Fur-
thermore, by extension of the sugar chains at the C3 or C4 hydroxyl
group, derivatives including chitotriose thiazolines [25], Gal-b1,3-
GlcNAc-thiazoline [26,27] and Man9GlcNAc-thiazoline [28,29]
have been developed as potent inhibitors against GH18 chitinase,
GH20 lacto-N-biosidase and GH85 endo-b-N-acetylglucosamini-
dase, respectively.
However, even at a concentration of 3 mM, NGT could not inhi-
bit the activity of the bacterial GH20 b-GlcNAcase from Serratia
marcescens (SmChb), which is a chitinolytic b-GlcNAcase with an
essential function in chitin degradation [17]. In this work, we also
found NGT to be a poor inhibitor with a Ki of 79 lM against
OfHex1, the insect molting-indispensable chitinolytic b-GlcNAcase
from the highly destructive pest Ostrinia furnacalis [30,31]. Because
GH20 chitinolytic b-GlcNAcases play vital roles in the survival of
agricultural pests and human pathogens, selective inhibitors for
chitinolytic b-GlcNAcases are potential drugs or agrichemicals. To
develop an NGT-based inhibitor against GH20 chitinolytic b-
GlcNAcases, we report here the crystal structure of the OfHex1-
NGT complex. Based on the crystal structure, a submicromolar
inhibitor NMAGT was obtained. The molecular basis of the potency
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(MD) simulations and site-directed mutagenesis.
2. Materials and methods
2.1. Enzyme preparation
OfHex1 and the mutant OfHex1 (E328A) were expressed in
Pichia pastoris and puriﬁed using metal-chelating chromatography
as described previously [31]. SmChb was expressed in Escherichia
coli and puriﬁed using metal-chelating chromatography as
described previously [32]. Bacterial b-GlcNAcase from Streptomyces
plicatus (SpHex) was purchased from New England Biolabs (USA).
2.2. Enzyme activity assay
The enzymatic activities of b-GlcNAcases were measured at
25 C using 4-nitrophenyl-N-acetyl-b-acetylglucosamine (pNP-b-
GlcNAc, Sigma–Aldrich) as a substrate. OfHex1, OfHex1 (E328A)
and SmChb were assayed in 20 mM sodium phosphate buffer (pH
6.0). SpHex was assayed in 20 mM sodium acetate buffer (pH
4.0). After incubating for an appropriate time, 0.5 M Na2CO3 was
added to the reaction mixture, and the absorbance at 405 nm
was monitored using a Sunrise microplate reader (TECAN). The
Km values of OfHex1, OfHex1 (E328A), SmChb and SpHex for the
substrate pNP-b-GlcNAc were determined to be 0.15 ± 0.03 mM,
0.16 ± 0.03 mM, 0.24 ± 0.04 mM and 0.47 ± 0.07 mM, respectively
(Fig. S1). However, all of these test enzymes encountered substrate
inhibition effects when the pNP-b-GlcNAc concentration was
higher than 0.2 mM (Fig. S1). Thus, the range of substrate concen-
trations was chosen to be between 0 and 0.2 mM to determine the
Ki values. The range of inhibitor concentration of NGT and NMAGT
was then determined to be around the Ki values obtained. The Ki
values and types of inhibition were determined by Lineweaver–
Burk plots of enzymes at different inhibitor concentrations.
2.3. Fluorescence spectroscopy
For the tryptophan ﬂuorescence titration, NGT (0–16 mM) and
NMAGT (0–16 lM) were titrated into 200 ll of 10 lM OfHex1 in
20 mM sodium phosphate buffer (pH 6.0) at 25 C. The ﬂuores-
cence was scanned from 300 to 480 nm using a Varioskan FlashFig. 1. The catalytic mechanism and the NGTmicroplate reader (Thermo, USA) with the excitation wavelength
of 280 nm. The Kd calculation was performed as described previ-
ously [19].
2.4. Crystallization and data collection
Crystallization experiments were performed by the hanging
drop-vapor diffusion method at 4 C. OfHex1 was desalted in
20 mM bis-Tris with 50 mM NaCl (pH 6.5) and concentrated to
7.0 mg ml1 by ultracentrifugation. The crystal of NGT-complexed
OfHex1 was obtained within 2 weeks with 20-fold excess of NGT in
the mother liquid (100 mM HEPES (pH 7.5), 200 mM MgCl2, 35%
PEG400). Diffraction data were collected at Shanghai Synchrotron
Radiation Facility, BL-17U (ADSC Quantum 315r CCD at 100 K),
and processed using HKL2000 [33].
2.5. Structure determination and reﬁnement
The structure of OfHex1-NGT complex was solved by molecular
replacement with Molrep [34] using the structure of native OfHex1
(PDB accession number: 3NSM) as the search model. Structure
reﬁnement was achieved using REFMAC5 [35] and CNS [36]. The
molecular models were manually built and extended using Coot
[37]. The stereochemistry of the models was checked by PRO-
CHECK [38]. All structural ﬁgures were prepared by PyMOL (DeL-
ano Scientiﬁc LLC, USA).
2.6. Compound synthesis
NGT was kindly provided by Professor Spencer Knapp at the
State University of New Jersey, USA. Thiamet-G was purchased
from Sigma–Aldrich. The synthesis of NMAGT was performed by
Prof. Jianjun Zhang at China Agricultural University according to
the reference [39].
To a solution of the hydrochloride salt of 2-amino-2-deoxy-
1,3,4,6-tetra-O-acetyl-b-D-glucopyranose (3.06 g, 7.79 mmol) in
acetonitrile (120 ml) was added triethylamine (1.41 g,
13.97 mmol) followed by methyl isothiocyanate (1.88 g,
25.65 mmol). The reaction mixture was heated to reﬂux and stirred
until the reaction was judged complete based on TLC. The reaction
was then concentrated in vacuo, and the resulting mixture was
resuspended in dichloromethane. The organic mixture was washed-based inhibitors of GH20 b-GlcNAcases.
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aqueous layer was extracted twice with dichloromethane. The
organic phases were combined and dried over MgSO4, ﬁltered,
and concentrated in vacuo. The concentrated mixture was puriﬁed
via ﬂash column chromatography on silica gel (EtOAc:hexanes,
1:1), providing 2-deoxy-2-methylthioureido-1,3,4,6-tetra-O-
acetyl-b-D-glucopyranose (2.64 g, 81% yield) (1). The 1H NMR spec-
trum was identical to the published data [39].
The above obtained compound 1 (0.914 g, 2.18 mmol) was
dried over high vacuum for 2 h and dissolved in dry DCM, and
SnCl4 (2.26 g, 8.66 mmol) was added dropwise. The reaction was
stirred at room temperature overnight (16 h). The reaction was
quenched with saturated aqueous NaHCO3 until the solution was
basic and no more gas was evolved. The aqueous layer was
extracted three times with DCM, and the combined organic layers
were dried with MgSO4, ﬁltered and concentrated. The crude mate-
rial was puriﬁed by ﬂash chromatography (silica gel, EtOAc), pro-
viding 3,4,6-tri-O-acetyl-1,2-dideoxy-20-methylamino-a-D-
glucopyranoso-[2,1-d]-D20-thiazoline (2) as an oil (0.60 g, 77%
yield). The 1H NMR spectrum of 2 was identical to the published
data [39].
Compound 2 (0.18 g, 0.50 mmol) was dried over high vacuum
for 2 h and dissolved in anhydrous MeOH. Solid K2CO3 was added
to the solution until it was basic, and the reaction was stirred at
room temperature (5 h). A white solid, the desired product, precip-
itated out of solution. The ﬁnal product, 1,2-dideoxy-20-methyl-
amino-a-D-glucopyranoso-[2,1-d]-D20-thiazoline (NGMAT), was
puriﬁed by isolating this solid and washing it several times with
MeOH (0.076 g, 64% yield). 1H NMR (300 MHz, D2O) d 2.74 (s, 3H,
-NCH3), 3.45–3.49 (m, 1H, H-5), 3.53–3.59 (m, 2H, H-4, H-6’),
3.69–3.74 (m, 1H, H-6), 3.93 (t, 1H, J = 5.0 Hz, H-3), 4.09 (t, 1H,
J = 5.9 Hz, H-2), 6.21 (d, 1H, J = 6.4 Hz, H-1) (Fig. S2). 13C NMR
(300 MHz, D2O) d 29.84 (-NCH3), 61.20 (C-6), 69.04, 72.65, 73.11,Fig. 2. Biochemical characterization of NGT and NMAGT as OfHex1 inhibitors. Lineweav
determination of NGT (C) and NMAGT (D) against OfHex1 by tryptophan ﬂuorescence q74.23, (C2, C3, C4, C5), 88.24 (C-1), 164.14 (–N@C–) (Fig. S3).
HRMS: m/z: for C8H14N2O4S [M+H+], calcd: 235.0747 [M+H+];
found: 235.0751 (Fig. S4).
2.7. Molecular docking
The PDB ﬁles of GlcNAc-oxazoline, NMAGT and ethyl-NGT were
generated by PRODRG [40]. The PDB ﬁle of the ligand-free OfHex1
was prepared by PyMOL from the NGT-complexed structure of
OfHex1 (PDB code: 3OZO). The PDBQT ﬁles of the proteins and
compounds were prepared by MGLTools [41]. Afﬁnity grids of
50  50  50 Å positioned on the center of the NGT in OfHex1 were
calculated using AutoGrid4 [41]. Molecular dockings were per-
formed by AutoDock4 [41] using the Lamarckian genetic algorithm
with a population size of 150 individuals, 25000000 energy evalu-
ations and 27000 generations. Plausible docking models were
selected from the most abundant cluster (RMSD = 2 Å) with the
lowest binding energy.
2.8. Molecular dynamics simulations
MD simulations were conducted with YASARA (13.9.8) [42]
using the AMBER03 force ﬁeld [43]. The initial conformations of
OfHex1-NGT, OfHex1-GlcNAc-oxazoline, OfHex1-NMAGT and
OfHex1-ethyl-NGT were obtained through X-ray crystal structure
(PDB ID: 3OZO) and docking studies, respectively. Force ﬁeld
parameters of NGT and NMAGT were generated by GAFF automat-
ically. Production MD simulation were performed for 10 ns in
explicit water at constant temperature (298 K) after initial energy
minimization. Long-range Coulomb interactions were included
using the particle-mesh Ewald (PME) method [44] with a cut-off
value of 7.86 Å. The counter ions were added by randomly replac-
ing water molecules using Na+ and Clwith a ﬁnal concentration ofer–Burk analysis of OfHex1 kinetics in the presence of NGT (A) and NMAGT (B); Kd
uenching.
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macro ﬁle (md_run) implemented within YASARA, and all of the
parameters were used as defaults. RMSD, RMSF and speciﬁc dis-
tances were analyzed by YASARA. Meanwhile, the hydrogen bond
interactions between ligand and protein were obtained through
VMD (1.9.1) [45].
3. Results and discussion
3.1. Crystal structure revealing the binding mode of NGT in OfHex1
Using pNP-b-GlcNAc as substrate, the Ki value of NGT for
OfHex1 was determined to be 79 ± 5 lM (Fig. 2A), which is 1100-
fold higher than for human HsHexA/B (Table 1). To reveal the bind-
ing mode of NGT in OfHex1, NGT was co-crystallized with OfHex1,
and the structure complex was reﬁned to a solution of 2.0 Å. The
statistics of the data collection and structure reﬁnement are shown
in Table S1. The coordinates and OfHex1-NGT complex have been
deposited in the Protein Data Bank with the accession number
3OZO.
The complex crystal structure revealed that the pyranose ring of
NGT is in an energy-favored conformation of 4C1. The a-face of the
pyranose ring stacks with W524, the residue constituting the bot-
tom of the active pocket. The C3-, C4- and C6-hydroxyl groups
form several hydrogen bonds with the residues R220, R220 and
E526, D477 and W490, respectively (Fig. 3A).
The thiazoline ring of NGT winds about 90 relative to the pyra-
nose ring and binds in a relatively closed region enclosed by the
residues D367, E368, W424, W448, Y475 and W524 (hereinafter
referred to in this paper as the thiazoline-binding site)
(Fig. 3A).The nitrogen and sulfur atoms in the thiazoline ring form
hydrogen bonds with residues D367 and Y475, respectively. It is
worth noting that the residue W448 is in a dual conformation,
namely, in either the ‘‘open-state’’ or ‘‘closed-state’’, indicating that
the thiazoline ring does not stack with residue W448 [31].
3.2. Structural comparison of NGT in different enzymes
To understand the reason for NGT acting as a poor inhibitor
against OfHex1, structural comparison was performed by superim-
posing the OfHex1-NGT complex with other GH20 b-GlcNAcase-
NGT complexes using PyMOL for pair-ﬁtting alignments. The activ-
ities of the chosen b-GlcNAcases could be inhibited by NGT with Ki
values lower than 1 lM that is NGT inhibits b-GlcNAcase from
Streptococcus gordonii (SgGcnA) with a Ki of 0.06 lM [46], human
b-GlcNAcases (HsHexA/B) with a Ki of 0.07 lM [47] and b-GlcNA-
case from Streptococcus pneumoniae (SpStrH) with a Ki of 1 lM
[48].
Structural comparison revealed that the interactions accounting
for OfHex1-NGT binding were highly conserved, including one
stacking interaction associated with the pyranose ring and four
hydrogen bonds associated with the C3-OH, C4-OH and N2 atoms,
respectively (Fig. 3B). However, signiﬁcant differences were
observed in the conformation of aromatic residues that constituteTable 1
Ki values of NGT, thiamet-G and NMAGT against GH20 chitinolytic b-GlcNAcases.
Enzyme Ki (lM)
NGT Thiamet-G NMAGT
OfHex1 79 ± 5 70 ± 3 0.13 ± 0.02
SmChb Not inhibited.a Not determined. 0.23 ± 0.04
SpHex 20 ± 2 Not determined. 24 ± 2
a Data from Ref. [17]. The Ki values represent the means ± standard deviations
from three independent sets of experiments.the thiazoline-binding site (W424, W448 and Y475 in OfHex1;
W267, W307 and Y309 in SgGcnA; W424, W405 and Y450 in
HsHexB; W439, F415 and Y469 in SpStrH) (Fig. 3B). These differ-
ences resulted in different pocket volumes. The pocket volume
was calculated using CASTp (probe radius of 1.0 Å) [49]. Six resi-
dues that constituted the thiazoline-binding site in OfHex1,
SgGcnA, HsHexB and SpStrH (Table S2) were selected for volume
calculation. The volume calculation indicated that OfHex1 pos-
sessed a 70.3 Å3 pocket for the ‘‘closed-state’’, while SgGcnA,
HsHexB and SpStrH had a pocket of 51.7 Å3, 38.2 Å3 and 47.4 Å3,
respectively, suggesting that OfHex1 had the largest thiazoline-
binding site and HsHexB had the smallest one. Here, only the vol-
ume for the ‘‘closed-state’’ of OfHex1 is considered since the
‘‘open-state’’ cannot be recognized by CASTp. We then hypothe-
sized that the large thiazoline-binding pocket of OfHex1might lead
to the inefﬁcient binding of NGT in OfHex1. Similarly, as indicated
by our previous work, the larger volume of the active pocket of
OfHex1 led to inefﬁcient binding of the inhibitor PUGNAc [50].
3.3. Design, synthesis and bioevaluation of NMAGT
Thiamet-G (Fig. 1B), a commercially available inhibitor for
GH84 O-GlcNAcases [24], is a NGT derivative with an ethylaminoFig. 3. Structural analysis of the binding mode of NGT in OfHex1. (A) The binding
mode of NGT in the substrate-binding pocket of OfHex1. The hydrogen bonds are
shown as dashed black lines. (B) The superimposition of the known NGT-complexed
b-GlcNAcases. The conserved residues of OfHex1, SgGcnA, HsHexB and SpStrH are
shown in blue, magenta, yellow and orange, respectively. The residues are labeled
according to the number in OfHex1, and the numberings in SgGcnA, HsHexB and
SpStrH are shown in Table S2. The conserved hydrogen bonds between NGT and
OfHex1, SgGcnA, HsHexB and SpStrH are shown as dashed lines in black, blue, red
and cyan, respectively.
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thiamet-G was applied to see if its bulky substituted thiazoline ring
could occupy the large pocket of OfHex1.Using pNP-b-GlcNAc as
substrate, thiamet-G was determined to inhibit OfHex1 with a Ki
of 70 ± 3 lM, which is similar to the Ki of NGT. However, thia-
met-G inhibits HsHexA/B with a Ki of 750 lM [24], which is
10700-fold higher than NGT. These results proved that the bulky
substituted thiazoline ring, as in thiamet-G, could not be accom-
modated by the small active pocket of HsHexA/B.
To know why thiamet-G exhibited poor inhibitory activity
against OfHex1, the binding mode of thiamet-G to OfHex1 was
analyzed by molecular docking using AutoDock [41]. To test the
reliability of the docking model, we ﬁrst tried to reproduce the
binding mode of NGT in the complex crystal structure of OfHex1-
NGT by setting the ‘‘lid’’ residue W448 as a ﬂexible residue. As
shown in Fig. S5A, the docking model of NGT with the lowest bind-
ing energy superimposed well with NGT in the structural complex,
suggesting that our docking model was reliable.
Thiamet-G was then docked into the active pocket of OfHex1
using the same docking procedure. All of the docking results indi-
cated that thiamet-G was in a completely different conformation
from NGT in the crystal structure (Fig. S5B), namely the thiazoline
ring was turned over by approximately 180 compared with NGT.
This result suggested that ethylamino substituted thiazoline ring
was too large to be accommodated by the active pocket of OfHex1.
Thus, NMAGT (Fig. 1B) was designed with a shorter substituent on
the thiazoline ring. Molecular docking analysis showed that
NMAGT could bind the active pocket of OfHex1 in a similar manner
to NGT, suggesting the length of the substituent was suitable
(Fig. S5C).
To prove our theoretical ﬁndings, NMAGT was synthesized.
Using pNP-b-GlcNAc as substrate, NMAGT was found to competi-
tively inhibit OfHex1 with a Ki of 0.13 ± 0.02 lM (Fig. 2B), whichFig. 4. MD simulations of the OfHex1-NGT, OfHex1-GlcNAc-oxazoline, OfHex1-NMAGT
NMAGT and ethyl-NGT during the MD simulations. (B) Superimposition of frames from
OfHex1-ethyl-NGT over 10-ns trajectory at 1-ns interval. (C) 3D representation of the
hydrogen bonds are shown as dashed black lines.is 600-fold lower than the Ki of NGT (79 ± 5 lM). The Kd values
of NGT and NMAGT for OfHex1 by tryptophan ﬂuorescence titra-
tion were determined to be 182 ± 14 lM (Fig. 2C) and
0.27 ± 0.05 lM (Fig. 2D), respectively, demonstrating that NMAGT
possessed a much higher binding afﬁnity to OfHex1.
The inhibitory activity of NMAGT against the bacterial GH20
chitinolytic b-GlcNAcases was also determined (Table 1). NMAGT
inhibited the activity of SmChb by a Ki value of 0.23 ± 0.04 lM, a
dramatic increase in inhibitory activity compared to NGT, which
could not inhibit SmChb even at a concentration of 3 mM [17].
3.4. Molecular dynamics simulation revealing the enhanced binding
afﬁnity of NMAGT to OfHex1
Unfortunately, attempts to obtain a crystal structure of the
OfHex1-NMGAT complex have been unsuccessful, and we there-
fore turned to MD simulation to gain insight into how NMAGT
might interact with OfHex1. To prove our hypothesis, we com-
pared the binding modes of NGT and NMAGT in OfHex1. The root
mean square deviation (RMSD) and root mean square ﬂuctuation
(RMSF) of the OfHex1 along with the MD trajectories are shown
in Fig. S6. Large differences in ligand ﬂuctuations between
OfHex1-NGT and OfHex1-NMAGT were observed during MD simu-
lations. As shown in Fig. 4A, the RMSD values of NGT changed
within a wide range of 0.5–2.3 Å in a period of 0–10,000 ps, while
the RMSD values of NMAGT changed very little, suggesting that
NMAGT binding to OfHex1 was more stable than NGT binding to
OfHex1. By superimposition of 10 frames from MD simulations,
Fig. 4B pictured a larger disturbance of NGT but a relatively stable
binding of NMAGT. And obviously, as shown in Fig. 4B, the residue
W448 is in a dual conformation namely in either ‘‘open-state’’ or
‘‘close-state’’ during MD simulations when NGT binds to OfHex1,
while it is mostly in a ‘‘closed-state’’ when NMAGT binds to OfHex1and OfHex1-ethyl-NGT complexes. (A) the RMSDs of the NGT, GlcNAc-oxazoline,
MD simulations of OfHex1-NGT, OfHex1-GlcNAc-oxazoline, OfHex1-NMAGT and
hydrogen bonds in the MD complexes of OfHex1-NGT and OfHex1-NMAGT. The
T. Liu et al. / FEBS Letters 589 (2015) 110–116 115(Fig. 4B). The dual conformation is also observed in the crystal
structure of the OfHex1-NGT complex too (Fig. 3A), suggesting
the binding of NGT is not tight.
As GlcNAc-oxazoline (Fig. 1B) is the actual reaction intermedi-
ate of GH20 b-GlcNAcases, MD simulations of GlcNAc-oxazoline
binding to OfHex1 were also performed. As shown in Fig. 4A, RMSD
values of GlcNAc-oxazoline changed very little compared to NGT.
By superimposition of 10 frames from MD simulations, Fig. 4B
depicts a larger disturbance of NGT but a stable status of GlcNAc-
oxazoline, supporting the reliability of our model.
To determine the role of the extra-circular nitrogen atom on the
potency of NMAGT, MD simulations of ethyl-NGT (Fig. 1B) were
performed. As shown in Fig. 4A, the RMSD values of ethyl-NGT
changed within a wide range of 0.25–1.75 Å in a period of 0–
10,000 ps, while the RMSD values of NMAGT changed very little,
suggesting that NMAGT binding to OfHex1 might be more stable
than ethyl-NGT binding to OfHex1. By the superimposition of 10
frames from MD simulations, Fig. 4B depicts a larger disturbance
of ethyl-NGT but a relatively stable binding of NMAGT. This result
seems to support the positive role of the extra nitrogen atom for
the binding of NMAGT in OfHex1. However, no hydrogen bonds
could be found between active-pocket residues and the thiazoline
nitrogen atoms in either NMAGT or ethyl-NGT (Table S3).
The hydrogen bonds with high occupancy (>40%) between
OfHex1 and NGT or NMAGT are shown in Fig. 4C and Table S3.
The most obvious difference was related to the residue E328,
which was previously known as an important residue for stabiliz-
ing the GlcNAc at the subsite +1 in OfHex1 [31,51]. E328 formed
two hydrogen bonds with NMAGT but did not interact with NGT.
To validate the importance of E328 during NMAGT binding, the
Ki of NMAGT for the mutant OfHex1 (E328A) was determined to
be 1.27 ± 0.08 lM, which is a 9.8-fold increase compared to the
wild-type (Fig. S7B). However, the mutation did not affect Ki when
NGT was the inhibitor (Fig. S7A). The structure-equivalent residues
in SmChb and SpHex to E328 in OfHex1 were Q494 and G277,
respectively [51]. Because a glutamine instead of a glycine could
form a hydrogen bond similarly to a glutamate, the higher inhibi-
tory activity of NMAGT against SmChb (Ki = 0.23 ± 0.04 lM) than
against SpHex (Ki = 20 ± 2 lM) also suggested the importance of
E328 (Table 1).4. Conclusion
We ﬁrst reported a crystal structure of NGT complexed with an
insect molting-indispensable GH20 chitinolytic b-GlcNAcase
OfHex1. Based on this crystal structure, a derivative of NGT was
obtained and determined to be a submicromolar inhibitor against
OfHex1. Because NGT is a poor inhibitor against GH20 chitinolytic
b-GlcNAcases, this work suggested that the size of the active
pocket of these enzymes was a concern for developing inhibitors.
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